BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33324805)

  • 1. Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors.
    Dighe SN; Tippana M; van Akker S; Collet TA
    ACS Omega; 2020 Dec; 5(48):30971-30979. PubMed ID: 33324805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
    Feng B; Li X; Xia J; Wu S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined
    Ibrar A; Khan A; Ali M; Sarwar R; Mehsud S; Farooq U; Halimi SMA; Khan I; Al-Harrasi A
    Front Chem; 2018; 6():61. PubMed ID: 29632858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease.
    Costagli C; Galli A
    Biochem Pharmacol; 1998 May; 55(10):1733-7. PubMed ID: 9634011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies.
    de Almeida RBM; Barbosa DB; do Bomfim MR; Amparo JAO; Andrade BS; Costa SL; Campos JM; Cruz JN; Santos CBR; Leite FHA; Botura MB
    Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
    Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
    Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.
    Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z
    J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cholinesterase activities and genes are present in amphioxus.
    Sutherland D; McClellan JS; Milner D; Soong W; Axon N; Sanders M; Hester A; Kao YH; Poczatek T; Routt S; Pezzementi L
    J Exp Zool; 1997 Feb; 277(3):213-29. PubMed ID: 9062997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
    García-Ayllón MS; Sáez-Valero J; Muñoz-Delgado E; Vidal CJ
    Neuroscience; 2001; 107(2):199-208. PubMed ID: 11731094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.
    Lodarski K; Jończyk J; Guzior N; Bajda M; Gładysz J; Walczyk J; Jeleń M; Morak-Młodawska B; Pluta K; Malawska B
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):98-106. PubMed ID: 24666296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.